Vanguard Capital Management’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.62M Hold
675,185
– – ﹤0.01% 3109
2026
Q2
$4.78M Sell
675,185
-406,895
-38% -$2.32M ﹤0.01% 3140
2026
Q1
$5.07M Buy
+1,082,080
New +$8.4M ﹤0.01% 3052

Other funds holding DERM

Vanguard Capital Management's DERM Position: Q3 2026 in Review

Vanguard Capital Management held its Journey Medical (DERM) position steady in Q3 2026 at 675,185 shares worth $4.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

Vanguard Capital Management first reported a position in DERM in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.07M in Q1 2026. 48 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • Vanguard Capital Management held 675,185 shares of Journey Medical worth $4.62M as of Q3 2026.
  • Vanguard Capital Management left its Journey Medical share count unchanged in Q3 2026.
  • Journey Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3109 holding.
  • Vanguard Capital Management first reported a position in Journey Medical in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Journey Medical position peaked at $5.07M in Q1 2026.
  • 48 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.